		Clinical Features	Time to Death		AGE		GENDER		HISTOLOGICAL.TYPE		DISTANT.METASTASIS		LYMPH.NODE.METASTASIS		COMPLETENESS.OF.RESECTION		NUMBER.OF.LYMPH.NODES		TUMOR.STAGECODE		NEOPLASM.DISEASESTAGE	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	t-test_P	t-test_Q	t-test_P	t-test_Q	Chi-square test_P	Chi-square test_Q
APC	57 (83%)	12	0.53528	1	0.89685	1	1	1	0.63353	1	0.36178	1	0.84631	1	0.69253	1	0.53603	1	NA	NA	0.20172	1
KRAS	38 (55%)	31	0.023262	0.628	0.53373	1	0.32899	1	0.26979	1	0.32689	1	0.80034	1	0.040461	1	0.36341	1	NA	NA	0.69951	1
TP53	45 (65%)	24	0.88564	1	0.97605	1	0.80343	1	0.23763	1	0.72988	1	0.95813	1	0.62366	1	0.50989	1	NA	NA	0.48808	1
